कॉन्कॉर्ड बायोटेक शेअर किंमत

The 41st Annual General Meeting Meeting of the Members of the Company was held on Friday July, 31, 2026 at 12:00 Noon through VC/OAVM. The summary of the proceedings are published herewith.

• बीएसई इंडिया
• 6 तास 8 मिनिटांपूर्वी

Unaudited Standalone and Consolidated Financial Results for the first quarter ended on June 30, 2026

• बीएसई इंडिया
• 7 तास 27 मिनिटांपूर्वी

<h3><span style="font-size:16px;"><strong>Biotechnology company Concord Biotech announced Q1FY27 results</strong></span></h3><p _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">एकत्रित फायनान्शियल हायलाईट्स:</strong></p><ul><li _ngcontent-ng-c3377174747="">Q1FY27 साठी कामकाजाचा एकूण महसूल ₹25,748.90 आहे lakh, marking a YoY growth of 26.23% from Rs 20,398.76 लाख Q1FY26 मध्ये, आणि QoQ मध्ये ₹32,607.96 पासून 21.03% घट लाख Q4FY26 मध्ये.</li><li _ngcontent-ng-c3377174747="">Q1FY27 साठी एकूण उत्पन्न ₹ 27,031.49 पर्यंत पोहोचले lakh, reflecting a 24.19% YoY increase compared to Rs 21,766.52 लाख आणि 20.83% QoQ घट ₹ 34,142.90 पासून लाख.</li><li _ngcontent-ng-c3377174747="">The consolidated net profit for Q1FY27 was reported at Rs 5,769.69 लाख, जे ₹4,405.78 पासून 30.96% च्या वार्षिक वाढीचे प्रतिनिधित्व करते लाख Q1FY26 मध्ये, आणि 34.78% QoQ ची घट ₹ 8,846.69 पासून लाख Q4FY26 मध्ये.</li><li _ngcontent-ng-c3377174747="">Q1FY27 साठी टॅक्स पूर्वीचा नफा ₹7,834.31 होता lakh, indicating a YoY increase of 33.39% from Rs 5,873.18 lakh in Q1FY26, while declining by 31.32% QoQ रु. 11,407.54 पासून लाख Q4FY26 मध्ये.</li><li _ngcontent-ng-c3377174747="">Other income for the quarter reached Rs 1,282.59 लाख Q1FY27 मध्ये, ₹ 1,367.76 पासून लाख Q1FY26 मध्ये आणि ₹ 1,534.94 लाख Q4FY26 मध्ये.</li><li _ngcontent-ng-c3377174747="">Q1FY27 साठी एकूण कॉम्प्रिहेन्सिव्ह इन्कम ₹7,475.83 होते लाख, ₹4,123.90 च्या तुलनेत लाख Q1FY26 मध्ये, 81.28% ची वार्षिक वाढ चिन्हांकित करते.</li></ul><p _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">स्टँडअलोन फायनान्शियल हायलाईट्स:</strong></p><ul><li _ngcontent-ng-c3377174747="">Q1FY27 साठी कामकाजाचा महसूल ₹ 26,051.71 होता लाख, जे ₹20,398.76 पासून 27.71% ची वार्षिक वाढ दर्शविते lakh in Q1FY26, and a QoQ decrease of 20.06% from Rs 32,589.20 lakh in Q4FY26.</li><li _ngcontent-ng-c3377174747="">Q1FY27 साठी एकूण उत्पन्न ₹27,361.35 आहे लाख, ₹ 21,766.52 च्या तुलनेत lakh in Q1FY26 (up 25.70% YoY) and Rs 34,143.37 lakh in Q4FY26 (down 19.86% QoQ).</li><li _ngcontent-ng-c3377174747="">Standalone net profit for Q1FY27 was reported at Rs 6,119.37 lakh, representing a significant YoY growth of 43.76% from Rs 4,256.55 lakh in Q1FY26, while falling 32.02% QoQ from Rs 9,002.21 लाख Q4FY26 मध्ये.</li><li _ngcontent-ng-c3377174747="">Q1FY27 साठी टॅक्स पूर्वीचा नफा ₹ 8,220.96 पर्यंत पोहोचला लाख, ₹5,723.95 च्या तुलनेत लाख Q1FY26 मध्ये आणि ₹ 11,837.76 लाख Q4FY26 मध्ये.</li><li _ngcontent-ng-c3377174747="">Total comprehensive income for the quarter was Rs 7,824.64 lakh in Q1FY27, up from Rs 3,974.67 lakh in Q1FY26.</li></ul><p _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">बिझनेस हायलाईट्स:</strong></p><ul><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Acquisition of Subsidiary:</strong> Celliimune Biotech Private Limited, which was incorporated on January 15, 2025, has been acquired by Concord Biotech Limited as on April 02, 2026. Consequently, Celliimune Biotech Private Limited has become a wholly owned subsidiary from April 02, 2026.</li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Consolidated Entities:</strong> The consolidated financial results include the results of the Parent Company (Concord Biotech Limited), its wholly owned subsidiaries (Concord Lifegen Limited and Celliimune Biotech Private Limited), its subsidiary (Stellon Biotech Inc.), and its joint venture (Concord Biotech Japan K.K.).</li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Regulatory Update:</strong> The company noted the notification of four Labour Codes by the Government of India in November 2025, which consolidate 29 existing labour laws. The Group had recognized an incremental liability of Rs 327.54 lakh towards employee benefit obligations in FY26 following an assessment based on the revised definition of wages under the New Labour Codes.</li></ul><p><a class="lb" href="/marathi/get-document/post/pdf/5758367/" target="_blank">रिझल्ट PDF</a></p>

• ट्रेंडलाईन
• 7 तास 39 मिनिटांपूर्वी